<ref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="B115"><label>115</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perepu</surname><given-names>US</given-names></name><name><surname>Chambers</surname><given-names>I</given-names></name><name><surname>Wahab</surname><given-names>A</given-names></name><name><surname>Ten Eyck</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Dayal</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial</article-title>. <source>J Thromb Haemost</source>. (<year>2021</year>) <volume>19</volume>:<page-range>2225&#8211;34</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/jth.15450</pub-id>, PMID: <?supplied-pmid 34236768?><pub-id pub-id-type="pmid">34236768</pub-id>
</mixed-citation></ref>